Seegene Inc
상단으로
Contact Us

Product News You can check out the latest product information

  • Obtained approval of MFDS for AnyplexII™ STI-12 Detection

    AnyplexII™ STI-12 Detection has received approval from Korean Ministry of Food and Drug Safety (MFDS). This assay is a multiplex real-time PCR assay for detection of Candida albicans, Chlamydia trachomatis, Gardnerella vaginalis, Herpes simplex virus type 1, Herpes simplex virus type 2, Mycoplasma genitalium, Mycoplasma hominis, Neisseria gonorrhoeae, Treponema pallidum, Trichomonas vaginalis, Ureaplasma parvum and Ureaplasma urealyticum.

    Feb 13, 2020 Anyplex™Ⅱ STI-12 Detection

  • Obtained approval of MFDS for Allplex™ H. pylori&ClaR Assay

    Allplex™ H.pylori & ClaR Assay has received approval from Korean Ministry of Food and Drug Safety (MFDS). This assay is a multiplex real-time PCR assay for detection of H.pylori and the most frequent point mutations (A2142G and A2143G) responsible for clarithromycin resistance within the H.pylori 23S rRNA gene.

    Dec 27, 2019 Allplex™ H. pylori & ClaR Assay

  • Obtained CE-IVD marking for Allplex™ STI Essential Assay Q(MH,UU)

    Seegene has received CE-IVD mark under European Union on In Vitro Diagnostics Medical Devices for Allplex™ STI Essential Assay Q(MH,UU). This assays?is a multiplex real-time PCR assay to simultaneously detect 7 pathogens causing sexually transmitted infections. Based on Seegene’s proprietary MuDT™ Technology, this assay reports multiple Ct value or quantitative result of each pathogen in a single channel. The quantitative result of Mycoplasma hominis and Ureaplasma urealyticum helps effective management of STIs.

    May 30, 2019 Allplex™ STI Essential Assay Q(MH,UU)

  • Obtained CE-IVD marking for Allplex™ GI-EB Screening Assay

    Seegene has received CE-IVD mark under European Union on?In Vitro?Diagnostics Medical Devices for Allplex™ GI-EB Screening Assay. This assays?allows detection of 7 key bacteria associated with gastroenteritis. Based on Seegene’s proprietary MuDT™ technology, this assay reports multiple Ct values of each pathogen in a single channel using real-time PCR instruments.

    Feb 20, 2019 Allplex™ GI-EB Screening Assay

  • Obtained CE-IVD marking for Allplex™ H. pylori & ClariR Assay

    Seegene has received CE-IVD mark under European Union on?In Vitro?Diagnostics Medical Devices for Allplex™ H. pylori & ClariR Assay. This assays is a Multiplex Real-time PCR assay that detects and identifies H. pylori and the most frequent point mutations (A2142G, A2143G and A2142C) responsible for clarithromycin resistance within the H. pylori 23S rRNA gene.

    Feb 20, 2019 Allplex™ H. pylori & ClariR Assay

  • Obtained CE-IVD marking and MFDS approval for Allplex™ PneumoBacter Assay

    Seegene has received CE-IVD mark under European Union on?In Vitro?Diagnostics Medical Devices, and received approval from Korean Ministry of Food and Drug Safety (MFDS) for Allplex™ PneumoBacter Assay. This assays?is a Multiplex Real-time PCR assay that detects and identifies 7 major respiratory bacteria associated with pneumonia. Based on Seegene's proprietary MuDT™ technology, this assay reports multiple Ct values of each pathogen in a single channel.

    Feb 20, 2019 Allplex™ PneumoBacter Assay

  • Obtained CE-IVD marking for Allplex™ GI-Helminth(I) Assay

    Seegene has received CE-IVD mark under European Union on?In Vitro?Diagnostics Medical Devices for Allplex™ GI-Helminth(I) Assay. This assays?allows detection of 1 protozoa and 8 helminths which are highly pathogenic parasites. Based on Seegene’s proprietary MuDT™ technology, this assay reports multiple Ct values of each pathogen in a single channel using real-time PCR instruments.

    Jan 31, 2019 Allplex™ GI-Helminth(I) Assay

  • Obtained CE-IVD marking for Allplex™ Vaginitis Screening Assay

    Seegene has received CE-IVD mark under European Union on?In Vitro?Diagnostics Medical Devices for Allplex™ Vaginitis Screening Assay. This assay is a Multiplex Real-time PCR assay that detects and identifies major pathogens related vaginitis simultaneously. Based on Seegene’s proprietary MuDT™ Technology, this assay reports multiple Ct values of each pathogen in a single channel. And it provides automated interpretation of BV using Seegene Viewer based on quantification information of major targets.

    Jan 25, 2019 Allplex™ Vaginitis Screening Assay